Comparison of Landmark-Based Versus Transverse Carpal Ligament Penetrating Corticosteroid Injection for Carpal Tunnel Syndrome: A Prospective Randomized Trial
Not Applicable
Recruiting
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0004890
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1)Between March 2020 and March 2021, 30 patients between the ages of 18 and 80 who was diagnosed with carpal tunnel syndrome in both hands by clinical symptoms, and findings on the physical examination with confirmation by nerve conduction studies
2)Less than a year of symptom occurrence
Exclusion Criteria
1)Thenar atrophy
2)History of previous carpal tunnel surgery or steroid injection
3)Moderate to severe osteoarthritis of the upper extremities
4)History of peripheral vascular disease, polyneuropathy, cervical radiculopathy, focal nerve entrapment other than CTS, hypothyroidism, chronic synovitis such as rheumatoid arthritis
5)Allergic reaction to steroid
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Boston carpal tunnel questionnaire-symptom
- Secondary Outcome Measures
Name Time Method Pain VAS scale, skin hypopigmentation scale, grip strength, Boston carpal tunnel questionnaire-function